DepoMed, Inc. (NASDAQ: DEPO) reported Q1 EPS of ($0.16), $0.08 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $12.88 million.

For earnings history and earnings-related data on DepoMed, Inc. (DEPO) click here.

Earnings